Effect of Rajayoga Meditation on Serum Cholesterol and HDL
Background: Meditation has a number of positive effects on physiology of human body. It has shown to reduce blood pressure, heart rate and serum cholesterol levels thus reducing the risk of coronary artery disease.
Objectives: The present study is contemplated to highlight the hemodynamic and biochemical effects of Rajyoga meditation by studying its impact on serum cholesterol and serum HDL levels of the individuals.
Materials and Methods: The study was conducted on 100 healthy people selected from Brahma Kumari Ashram Amritsar. Group I included 50 subjects meditation regularly for at least 1 hour a day for last 2-5 yrs, Group II included 50 subjects in the same age group who did not perform any meditation technique. Serum cholesterol and HDL were measured by the respective kits. Results were analysed statistically.
Results: This data shows that mean value of serum cholesterol in case of meditator males and females was significantly lower than in non meditators Also, the mean values for the S.Cholesterol/HDL ratio were also significantly lower in meditators and non meditators.
Conclusions: Persons practising Rajayoga Meditation regularly are at a lower risk of developing cardiovascular diseases as compared to those who do not perform any meditation at all. So it can be safely conclude that meditation has a positive effect on cardiovascular system and with regular practice of meditation reduces the risk of developing cardiovascular diseases.
Neuberry CR. Tension and relaxation in the individual. Int Dent Journ 1972;29(2):173-82.
Levy RI. Review: Declining mortality in coronary heart disease. Atherosclerosis 1981;1(5):312-325.
Kaplan NM. The Deadly Quartet. Arch Intern Med 1989;149:1514.
Gordon DJ, Probstfield JL, Garrison RJ. High density lipoprotein cholesterol and cardiovascular disease. Circulation 1989;79:80.
Foosati P. Serum Triglycerides determined colorimetrically with an enzyme that produces H2O2. Clin Chem 1982;28:20772080.
Richmond W. Preparation and properties of a cholesterol oxidase from Nocardia sp. and its applications to the enzymatic assay of total chplesterol in serum. Clin Chem 1973;19:1350-1356.
Cooper MJ, Aygen MM. A relaxation technique in the management of hypercholesterolemia. J Human Stress 1979;5(4):24-27.
Cooper MI. Effect of relaxation on blood pressure and serum cholesterol. Act Nerv Super (Praha) 1982;3(2):428-36.
Patel C, Marmot MG, Terry DJ, Carruthers M, Hunt B, Patel M. Trial of relaxation in reducing coronary risk: Four year follow up. Br Med Journ (Clin Res Ed) 1985;290(6475):1103-06.
Calderon R Jr, Schneider RH, Alexander CN, Myers HF, Nidich SI, Harey C. Stress, Stress reduction and hypercholesterolemia in African Americans. A Review Ethn Dis 1999;9(3): 451-62.
Gorton T, Castelli WP, hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. Am J Med 1977;62:707.
Corti MC, Guralnik JM, Salive ME, Harris T, Field TS, Wallace RB et al. HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA 1995;Aug16;274(7):539-44.
Malecka TE, Lewin KJ, Wazowski R, Piskorska D, Klimek K. Lipid profiles in polish adolescents from high and low risk families, tracking unfavourable lipid levels over a one year period. Acta Paediatr 2000;89(8):908-14.
Ridker PM, Glynn RJ, Hennekens CH. CReactive Protein adds to the predictive values of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998 May26;97(20):2007-11.
Harinnath K, Malhotra AS, Pal K, Prasad R, Kumar R, Kain TC. Effects of Hathayoga and Omkar meditation on cardiorespiratory performance, psychologic profile and melatonin secretion. The journal of Alt and Complementary Medicine 2004;10(2):261268.
Singh S, Kyizom T, Singh KP, Tandon OP, Madhu SV. Influence of pranayams and yogasanas on serum insulin, blood glucose and lipid profile in type II diabetes. Ind J Clin Biochem 2008;23(4):365-368.
Vyas R, Raval KV, Dixit N. Effect of Rajayoga Meditation in the lipid profile of postmenopausal women. Indian J Physiol Pharmacol 2008;52(4):420-424.
Mackness B, Mackness M. High Density Lipoprotein: Why all the fuss? Ann Clin Biochem 2009;46:5-7.
Shilpa S, Bairy KL. Guest Editorial. HDL-C as a new paradigm in atherosclerotic diseases. Indian J Physiol Pharmacol 2008; 53(4):319-326.
- There are currently no refbacks.